These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7606814)
1. Binding of coumarins to site I of human serum albumin. Effect of the fatty acids. Zatón AM; Ferrer JM; Ruiz de Gordoa JC; Marquínez MA Chem Biol Interact; 1995 Jul; 97(2):169-74. PubMed ID: 7606814 [TBL] [Abstract][Full Text] [Related]
2. The binding of benzopyranes to human serum albumin. A structure-affinity study. Ferrer JM; Leiton MJ; Zatón AM J Protein Chem; 1998 Feb; 17(2):115-9. PubMed ID: 9535273 [TBL] [Abstract][Full Text] [Related]
3. Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry. Aki H; Yamamoto M J Pharm Sci; 1994 Dec; 83(12):1712-6. PubMed ID: 7891299 [TBL] [Abstract][Full Text] [Related]
4. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. Noctor TA; Wainer IW; Hage DS J Chromatogr; 1992 Jun; 577(2):305-15. PubMed ID: 1400761 [TBL] [Abstract][Full Text] [Related]
5. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Kragh-Hansen U Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320 [TBL] [Abstract][Full Text] [Related]
6. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin. Panjehshahin MR; Bowmer CJ; Yates MS Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921 [TBL] [Abstract][Full Text] [Related]
7. Study of heterocycle rings binding to human serum albumin. Zatón AM; Villamor JP Chem Biol Interact; 2000 Jan; 124(1):1-11. PubMed ID: 10658898 [TBL] [Abstract][Full Text] [Related]
8. Binding and molecular dynamics studies of 7-hydroxycoumarin derivatives with human serum albumin and its pharmacological importance. Yeggoni DP; Gokara M; Manidhar DM; Rachamallu A; Nakka S; Reddy CS; Subramanyam R Mol Pharm; 2014 Apr; 11(4):1117-31. PubMed ID: 24495045 [TBL] [Abstract][Full Text] [Related]
9. Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Yamasaki K; Maruyama T; Kragh-Hansen U; Otagiri M Biochim Biophys Acta; 1996 Jul; 1295(2):147-57. PubMed ID: 8695640 [TBL] [Abstract][Full Text] [Related]
10. Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid. Hervé F; Rajkowski K; Martin MT; Dessen P; Cittanova N Biochem J; 1984 Jul; 221(2):401-6. PubMed ID: 6206846 [TBL] [Abstract][Full Text] [Related]
11. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis. Simard JR; Zunszain PA; Hamilton JA; Curry S J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140 [TBL] [Abstract][Full Text] [Related]
12. Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin. Nerli B; Romanini D; Picó G Chem Biol Interact; 1997 May; 104(2-3):179-202. PubMed ID: 9212783 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. Joseph KS; Moser AC; Basiaga SB; Schiel JE; Hage DS J Chromatogr A; 2009 Apr; 1216(16):3492-500. PubMed ID: 18926542 [TBL] [Abstract][Full Text] [Related]
14. Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin. Yamasaki K; Hyodo S; Taguchi K; Nishi K; Yamaotsu N; Hirono S; Chuang VTG; Seo H; Maruyama T; Otagiri M PLoS One; 2017; 12(6):e0180404. PubMed ID: 28662200 [TBL] [Abstract][Full Text] [Related]
15. Steric and allosteric effects of fatty acids on the binding of warfarin to human serum albumin revealed by molecular dynamics and free energy calculations. Fujiwara S; Amisaki T Chem Pharm Bull (Tokyo); 2011; 59(7):860-7. PubMed ID: 21720037 [TBL] [Abstract][Full Text] [Related]
16. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin. Anguizola J; Debolt E; Suresh D; Hage DS J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085 [TBL] [Abstract][Full Text] [Related]
17. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration. Storck J; Kirsten R Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271 [TBL] [Abstract][Full Text] [Related]
18. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Fehske KJ; Schläfer U; Wollert U; Müller WE Mol Pharmacol; 1982 Mar; 21(2):387-93. PubMed ID: 6808349 [TBL] [Abstract][Full Text] [Related]
19. Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs. Decroix MO; Zini R; Chaumeil JC; Tillement JP Biochem Pharmacol; 1988 Jul; 37(14):2807-14. PubMed ID: 3395358 [TBL] [Abstract][Full Text] [Related]
20. Investigation of binding mechanism of novel 8-substituted coumarin derivatives with human serum albumin and α-1-glycoprotein. Yeggoni DP; Manidhar DM; Suresh Reddy C; Subramanyam R J Biomol Struct Dyn; 2016 Sep; 34(9):2023-36. PubMed ID: 26440860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]